• Home >
  • Drug Discovery Technology--Drug Discovery and Biomanufacturing Technology for Drug Delivery, across Cancer, Autoimmune Diseases, and Rare Disorders

Drug Discovery Technology--Drug Discovery and Biomanufacturing Technology for Drug Delivery, across Cancer, Autoimmune Diseases, and Rare Disorders

08-Jan-2016  /  Research Code: D951-00-01-00-00  /  SKU: HC02747-GL-TA_19641  /  
Region: Global

USD 950.00

* Required Fields

USD 950.00

PAY BY INVOICE

Be the first to review this product

This issue depicts the current landscape and the new trends in a series of developments associated with drug discovery and development, including manufacturing for optimal drug delivery, across cancer research, autoimmune diseases, and rare disorders. The technologies incorporated in this study are related to cancer stem cells for cancer therapeutics, mammalian multi-protein clusters for drug discovery, and multi-biomarkers tests for autoimmune diseases. Special emphasis has been made on  biomanufacturing capabilities for drug delivery through precision particle fabrication.Keywords: cancer stem cells, antitumor drug, mammalian genetic model, metastatic adenocarcinoma, rheumatoid arthritis, lysosomal acid, li

Table of Contents

Drug Discovery Technology--Drug Discovery and Biomanufacturing Technology for Drug Delivery, across Cancer, Autoimmune Diseases, and Rare DisordersInnovations in drug delivery, across cancer, autoimmune diseases, and rare disordersDrug Discovery Platform to Target Cancer Stem Cells Multi-Biomarker Blood Test for Rheumatoid Arthritis Precision Encapsulation for Optimal Drug DeliveryMulti-Protein Clusters as Novel Drug Discovery ToolsNew Treatment for Patients with Lysosomal Acid Lipase Deficiency- Treatment for Bilateral Otitis Media Gets FDA NodNew Treatment Option for Metastatic Adenocarcinoma of PancreasAppendixPatent AnalysisPatent Analysis (continued)Industry Interactions




Related Research

US Medical Marijuana Market, Forecast to 2022

Release Date : 18-Jul-18

Region : Global

Why Now is The Time for Interoperable Healthcare Solutions?

Release Date : 05-Jul-18

Region : Global

Growth Insights for European Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2022

Release Date : 25-Jun-18

Region : Europe

Global Pharma Clinical Trial Patient Recruitment & Monitoring IT Solutions, Forecast to 2020

Release Date : 17-May-18

Region : North America

Global Laboratory Products Purchasing Trends, 2017–2018

Release Date : 15-Feb-18

Region : Global

Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021

Release Date : 07-Nov-17

Region : North America

Growth and Investment Opportunities in Nepal Healthcare Market, 2017

Release Date : 06-Nov-17

Region : South Asia, Middle East & North Africa

Growth Insights on the Global CRISPR/Cas9 Tools Market, 2017

Release Date : 31-Oct-17

Region : North America

Global Digital Pathology Market, 2017 Companies-To-Action

Release Date : 31-Oct-17

Region : Global

Growth Opportunities in the Western European Oncology Diagnostics Market, Forecast to 2021

Release Date : 30-Jun-17

Region : Europe

Related Subscription

• One-2-One Analyst briefing call •
• Access to published and new research deliverables •
• Mid year service review •
• Virtual Analyst briefing •
• GIL conference seats •

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.